author-photo

Santo Neri

University of Modena and Reggio Emilia

14

Papers

167

Citations

Citation Trend

Filter By

Papers (10) Sort By

Journal Conference Others

Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network

2019 Journal of Clinical Medicine
Show All
- Source
- Cite
- Save
Citations (16)
FEASIBILITY, TOLERABILITY AND EFFICACY OF CARFILZOMIB, LENALIDOMIDE AND DESAMETHASONE(KRD) IN RELAPSED REFRACTORY MYELOMA PATIENTS: A REAL-LIFE SURVEY OF THE SICILIAN MYELOMA NETWORK: PB2123

2019
Show All
- Source
- Cite
- Save
Citations (0)
A Multicenter Phase II Study of Twice-Weekly Bortezomib plus Rituximab in Patients with Relapsed Follicular Lymphoma: Long-Term Follow-Up

2017 Acta Haematologica
Show All
- Source
- Cite
- Save
Citations (3)
The role of tandem stem cell transplantation for multiple myeloma patients

2016 Expert Opinion on Biological Therapy
Show All
- Source
- Cite
- Save
Citations (10)
Long-Term Results in Multiple Myeloma After High-Dose Melphalan and Autologous Transplantation According to Response Categories in the Era of Old Drugs

2014 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (12)
A randomized trial with melphalan and prednisone versus melphalan and prednisone plus thalidomide in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplant

2011 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (26)
Prognostic models for diffuse large B-cell lymphoma in the rituximab era: a never-ending story

2010 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (74)
Phase II Study of Velcade (R) Plus Mabthera (R) In Relapsed Follicular Lymphomas.

2010
Show All
- Source
- Cite
- Save
Citations (0)
Phase II Study of Velcade® Plus Mabthera® In Relapsed Follicular Lymphomas

2010 Blood
Show All
- Source
- Cite
- Save
Citations (1)
ABVD vs. STANFORD V (SV) vs. MOPP-EBV-CAD (MEC) in advanced Hodgkin's lymphoma. Final results of the IIL HD9601 randomized trial

2004 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (9)